Adoptive Cell Therapy for Solid Tumors: Current Status in Melanoma and Next-Generation Therapies-Reference-Cited by-同舟云学术

Adoptive Cell Therapy for Solid Tumors: Current Status in Melanoma and Next-Generation Therapies

Published:2024-06 Issue:3 Volume:44 Page:
ISSN:1548-8748
Container-title:American Society of Clinical Oncology Educational Book
language:en
Short-container-title:Am Soc Clin Oncol Educ Book

Author:

Haanen John¹²³^ORCID,Los Christy¹,Phan Giao Q.⁴^ORCID,Betof Warner Allison⁵^ORCID

Affiliation:

1. Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands

2. Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands

3. Division of Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland

4. Division of Surgical Oncology, UConn Health, Neag Cancer Center, Farmington, CT

5. Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA

Abstract

Lifileucel or TIL has recently been FDA approved for metastatic melanoma patients as first cell therapy for a solid tumor. We discuss roll-out of TIL as new SOC and other upcoming new cell therapies.

Publisher

American Society of Clinical Oncology (ASCO)

Link

https://ascopubs.org/doi/pdfdirect/10.1200/EDBK_431608

Reference81 articles.

1. Adoptive Transfer of Tumor-Infiltrating Lymphocytes in Patients with Metastatic Melanoma: Intent-to-Treat Analysis and Efficacy after Failure to Prior Immunotherapies

2. Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy

3. Tumor Infiltrating Lymphocyte (TIL) Therapy for Solid Tumor Treatment: Progressions and Challenges

4. Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma

5. Lifileucel, a Tumor-Infiltrating Lymphocyte Therapy, in Metastatic Melanoma

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Advancements in Cell-Based Therapies in Melanoma;International Journal of Molecular Sciences;2024-09-12

2. Cutaneous Melanoma: An Overview of Physiological and Therapeutic Aspects and Biotechnological Use of Serine Protease Inhibitors;Molecules;2024-08-16

3. Advances in Melanoma: From Genetic Insights to Therapeutic Innovations;Biomedicines;2024-08-14